+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cancer Clinical Decision Tools Global Market Report 2024

  • PDF Icon

    Report

  • 250 Pages
  • February 2024
  • Region: Global
  • The Business Research Company
  • ID: 5733865
The cancer clinical decision tools market size has grown rapidly in recent years. It will grow from $0.45 billion in 2023 to $0.5 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth observed in the historical period can be attributed to several key factors. These include the escalating prevalence of cancer cases, the heightened complexity in cancer treatment methodologies, a growing demand for personalized medicine tailored to individual patient needs, an increased adoption of value-based healthcare models emphasizing patient outcomes, the expanding availability and utilization of comprehensive cancer-related data, and significant governmental support for cancer research and development initiatives. These elements collectively contributed to the growth and advancements in cancer care, fostering innovation and improvements in treatment strategies.

The cancer clinical decision tools market size is expected to see rapidly grown in the next few years. It will grow to $0.72 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The anticipated growth in the upcoming period can be attributed to several key factors. These include the global aging population, fostering a heightened focus on healthcare needs and cancer care among elderly individuals. Additionally, there's an increasing emphasis on patient engagement and shared decision-making, aiming to involve patients more actively in their treatment plans. This shift towards patient-centric care is expected to shape advancements in cancer treatment methodologies.

The ascending global cancer cases are poised to fuel growth in the cancer clinical decision tools market. As highlighted by the American Cancer Society in January 2022, the US alone is estimated to witness 1.9 million new cancer diagnoses and approximately 609,360 cancer-related deaths, translating to roughly 1,670 fatalities daily. Lung, prostate, bowel, and female breast cancers collectively account for 43% of all new cancer cases worldwide. This surge in cancer incidents globally is projected to intensify the demand for cancer clinical decision tools, expediting treatment decisions and thereby bolstering the market for these tools.

The proliferation of healthcare IT adoption is anticipated to be a driving force behind the cancer clinical decision tools market. Healthcare IT adoption denotes the assimilation and usage of information technology solutions within the healthcare domain. Health institutions strategically invest in information technology, encompassing electronic health records (EHRs) and clinical decision support systems (CDSS), aiming to optimize patient care. These systems integrate real-time patient data, treatment guidelines, and alert mechanisms for potential issues, ultimately enhancing cancer treatment outcomes. For example, a report published by the Healthcare Information and Management Systems Society (HIMSS) in January 2022 indicated that a significant 80% of healthcare providers planned to augment their technology investments over the next five years. This trend in healthcare IT adoption is expected to propel the cancer clinical decision tools market's growth trajectory. Key industry players in the cancer clinical decision tools market are exploring innovative offerings like the BenchMark Ultra Plus tissue staining system to gain a competitive edge. This advanced system streamlines tissue staining, enabling quicker and more accurate pathology outcomes. Launched by F. Hoffmann-La Roche AG in June 2022, the BenchMark Ultra Plus system showcases enhanced workflow efficiency, testing processes, and sustainability attributes. This innovation empowers pathologists to deliver high-quality, time-sensitive results to medical professionals and patients alike. The BenchMark Ultra Plus system marks a significant advancement in the BenchMark series, automating erstwhile manual slide-by-slide processes and revolutionizing cancer diagnostics.

In March 2021, NeoGenomics Laboratories, Inc., an American firm specializing in cancer genetics diagnostic testing and related services, completed the acquisition of Trapelo Health, LLC., for a total of $65 million. This strategic acquisition aims to bolster NeoGenomics' capabilities in precision oncology. By leveraging Trapelo Health's innovative decision-support platform, NeoGenomics intends to streamline diagnostic and treatment selection processes for healthcare professionals, laboratories, and payers. The platform facilitates real-time access to current clinical data, expedites workflow, and enhances clinical trial matching, ultimately offering patients improved access to medically suitable therapy options.

Major companies operating in the cancer clinical decision tools market include McKesson Corporation, Medical Information Technology Inc., Philips Healthcare, Siemens Healthineers AG, Elsevier B.V., Macmillan Publishers Limited, National Decision Support Company, IBM Watson Health, Cerner Corporation, GE Healthcare, Allscripts Healthcare Solutions Inc., Epic Systems Corporation, Koninklijke Philips N.V., RaySearch Laboratories AB, Elekta AB, Varian Medical Systems Inc., Accuray Incorporated, F. Hoffmann-La Roche Ltd., Flatiron Health Inc., Tempus Labs Inc., NantHealth Inc., Syapse Inc., Inspirata Inc., Oncora Medical Inc., Prognos Health Inc., Deep 6 AI Inc., PathAI Inc., Enlitic Inc., Ibex Medical Analytics Ltd., Zebra Medical Vision Ltd., Aidoc Medical Ltd.

North America was the largest region in the cancer clinical decision tools market in 2023. The regions covered in the cancer clinical decision tools market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the cancer clinical decision tools market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada. The market for cancer clinical decision tools consists of sales of risk assessment tools, Q-Cancer tools, and MacMillan’s cancer decision tool. Values in this market are ‘factory gate values,’ that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Among the primary types of cancer clinical decision tools are risk assessment tools (RAT) and Qcancer. Risk assessment tools evaluate a combination of risk factors, encompassing genetic, environmental, and behavioral elements, to translate these factors into estimations of an individual's likelihood of developing specific types of cancer. These tools serve to streamline risk models and facilitate assessments of an individual's cancer risk profile. These cancer clinical decision tools find application across various healthcare settings, including hospitals and clinics, supporting healthcare professionals in making informed decisions regarding patient care and potential referrals for further diagnostic assessments.

The cancer clinical decision tools market research report is one of a series of new reports provides cancer clinical decision tools market statistics, including cancer clinical decision tools industry global market size, regional shares, competitors with a cancer clinical decision tools market share, detailed cancer clinical decision tools market segments, market trends and opportunities, and any further data you may need to thrive in the cancer clinical decision tools industry. This cancer clinical decision tools market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary2. Cancer Clinical Decision Tools Market Characteristics3. Cancer Clinical Decision Tools Market Trends and Strategies
4. Cancer Clinical Decision Tools Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Cancer Clinical Decision Tools Market Size and Growth
5.1. Global Cancer Clinical Decision Tools Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Cancer Clinical Decision Tools Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Cancer Clinical Decision Tools Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Cancer Clinical Decision Tools Market Segmentation
6.1. Global Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Risk Assessment Tool(RAT)
  • Qcancer
6.2. Global Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital
  • Clinics
7. Cancer Clinical Decision Tools Market Regional and Country Analysis
7.1. Global Cancer Clinical Decision Tools Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Cancer Clinical Decision Tools Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Cancer Clinical Decision Tools Market
8.1. Asia-Pacific Cancer Clinical Decision Tools Market Overview
Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Cancer Clinical Decision Tools Market
9.1. China Cancer Clinical Decision Tools Market Overview
9.2. China Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Cancer Clinical Decision Tools Market
10.1. India Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Cancer Clinical Decision Tools Market
11.1. Japan Cancer Clinical Decision Tools Market Overview
11.2. Japan Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Cancer Clinical Decision Tools Market
12.1. Australia Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Cancer Clinical Decision Tools Market
13.1. Indonesia Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Cancer Clinical Decision Tools Market
14.1. South Korea Cancer Clinical Decision Tools Market Overview
14.2. South Korea Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Cancer Clinical Decision Tools Market
15.1. Western Europe Cancer Clinical Decision Tools Market Overview
15.2. Western Europe Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Cancer Clinical Decision Tools Market
16.1. UK Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Cancer Clinical Decision Tools Market
17.1. Germany Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Cancer Clinical Decision Tools Market
18.1. France Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Cancer Clinical Decision Tools Market
19.1. Italy Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Cancer Clinical Decision Tools Market
20.1. Spain Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Cancer Clinical Decision Tools Market
21.1. Eastern Europe Cancer Clinical Decision Tools Market Overview
21.2. Eastern Europe Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Cancer Clinical Decision Tools Market
22.1. Russia Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Cancer Clinical Decision Tools Market
23.1. North America Cancer Clinical Decision Tools Market Overview
23.2. North America Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Cancer Clinical Decision Tools Market
24.1. USA Cancer Clinical Decision Tools Market Overview
24.2. USA Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Cancer Clinical Decision Tools Market
25.1. Canada Cancer Clinical Decision Tools Market Overview
25.2. Canada Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Cancer Clinical Decision Tools Market
26.1. South America Cancer Clinical Decision Tools Market Overview
26.2. South America Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Cancer Clinical Decision Tools Market
27.1. Brazil Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Cancer Clinical Decision Tools Market
28.1. Middle East Cancer Clinical Decision Tools Market Overview
28.2. Middle East Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Cancer Clinical Decision Tools Market
29.1. Africa Cancer Clinical Decision Tools Market Overview
29.2. Africa Cancer Clinical Decision Tools Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Cancer Clinical Decision Tools Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Cancer Clinical Decision Tools Market Competitive Landscape and Company Profiles
30.1. Cancer Clinical Decision Tools Market Competitive Landscape
30.2. Cancer Clinical Decision Tools Market Company Profiles
30.2.1. McKesson Corporation
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Medical Information Technology Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Philips Healthcare
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Siemens Healthineers AG
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Elsevier B.V.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Global Cancer Clinical Decision Tools Market Competitive Benchmarking32. Global Cancer Clinical Decision Tools Market Competitive Dashboard33. Key Mergers and Acquisitions in the Cancer Clinical Decision Tools Market
34. Cancer Clinical Decision Tools Market Future Outlook and Potential Analysis
34.1 Cancer Clinical Decision Tools Market in 2028 - Countries Offering Most New Opportunities
34.2 Cancer Clinical Decision Tools Market in 2028 - Segments Offering Most New Opportunities
34.3 Cancer Clinical Decision Tools Market in 2028 - Growth Strategies
34.3.1 Market Trend-based Strategies
34.3.2 Competitor Strategies
35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic and Forecast Inflation Rates
35.4. Research Inquiries
35.5. About the Analyst
35.6. Copyright and Disclaimer

Executive Summary

Cancer Clinical Decision Tools Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer clinical decision tools market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for cancer clinical decision tools? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of covid 19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Report Scope


Markets Covered:

1) by Type: Risk Assessment Tool(RAT); Qcancer
2) by End-User: Hospital; Clinics

Key Companies Mentioned: McKesson Corporation; Medical Information Technology Inc.; Philips Healthcare; Siemens Healthineers AG; Elsevier B.V

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • McKesson Corporation
  • Medical Information Technology Inc.
  • Philips Healthcare
  • Siemens Healthineers AG
  • Elsevier B.V.
  • Macmillan Publishers Limited
  • National Decision Support Company
  • IBM Watson Health
  • Cerner Corporation
  • GE Healthcare
  • Allscripts Healthcare Solutions Inc.
  • Epic Systems Corporation
  • Koninklijke Philips N.V.
  • RaySearch Laboratories AB
  • Elekta AB
  • Varian Medical Systems Inc.
  • Accuray Incorporated
  • F. Hoffmann-La Roche Ltd.
  • Flatiron Health Inc.
  • Tempus Labs Inc.
  • NantHealth Inc.
  • Syapse Inc.
  • Inspirata Inc.
  • Oncora Medical Inc.
  • Prognos Health Inc.
  • Deep 6 AI Inc.
  • PathAI Inc.
  • Enlitic Inc.
  • Ibex Medical Analytics Ltd.
  • Zebra Medical Vision Ltd.
  • Aidoc Medical Ltd.

Methodology

Loading
LOADING...